Related Experiment Video
Updated: Jul 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Risk factors for antibiotic resistance in Streptococcus pneumoniae
1Rollins School of Public Health, Emory University, Atlanta, USA. keith.klugman@emory.edu
Insights
Streptococcus pneumoniae infections are a major cause of preventable death. Antimicrobial resistance complicates treatment, necessitating strategies like conjugate pneumococcal vaccines, though resistance is increasing in non-vaccine types.
Area of Science:
- Microbiology
- Infectious Diseases
- Vaccinology
Background:
- Streptococcus pneumoniae (pneumococcus) is a primary cause of vaccine-preventable mortality in pediatric and adult populations.
- The efficacy of managing pneumococcal infections is increasingly challenged by the emergence of antimicrobial resistance.
- Identifying risk factors associated with resistance is crucial for effective public health interventions.
Purpose of the Study:
- To summarize the key factors contributing to antimicrobial resistance in Streptococcus pneumoniae.
- To highlight the role of conjugate pneumococcal vaccines in combating resistant strains.
- To underscore the emerging challenge of resistance in non-vaccine serotypes.
Main Methods:
- Literature review of studies on Streptococcus pneumoniae resistance patterns.
- Analysis of identified risk factors for antimicrobial resistance.
- Evaluation of the impact of conjugate pneumococcal vaccines on resistance.
Main Results:
- Young age, hospitalization, daycare, antibiotic exposure, and HIV infection are significant risk factors for pneumococcal resistance.
- Conjugate pneumococcal vaccines provide protection against resistant strains within vaccine serotypes.
- A concerning trend of increasing antimicrobial resistance is observed in non-vaccine serotypes.
Conclusions:
- Antimicrobial resistance in Streptococcus pneumoniae poses a significant threat to public health, particularly in vulnerable populations.
- While conjugate vaccines are effective against vaccine serotypes, ongoing surveillance and development are needed to address resistance in non-vaccine types.
- Comprehensive strategies encompassing vaccination and judicious antibiotic use are essential for controlling pneumococcal infections and resistance.
Abstract:
Streptococcus pneumoniae (the pneumococcus) is the leading vaccine-preventable cause of death in children and adults. The management of pneumococcal infections is complicated by the development of resistance to antimicrobials. Risk factors for increased resistance include young age, isolation from the upper respiratory tract, hospitalisation, residence in an urban area, day care attendance, previous exposure to antibiotics, female gender, exposure to specific serotypes and clones, HIV infection and exposure to a class of drug to which resistance can be easily selected from a susceptible population of organisms. Conjugate pneumococcal vaccine affords protection from resistant strains belonging to vaccine serotypes, but resistance is emerging in non-vaccine types.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Antibiotic Selection

